Unable to load price data. Sorry.

¯\_(ツ)_/¯

Tengion Inc (NASDAQ:TNGN)

CAPS Rating: No stars

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

How do you think NASDAQ:TNGN will perform against the market?

Add Stock to CAPS Watchlist

All Players

11 Outperform
4 Underperform
 

All-Star Players

0 Outperform
2 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:TNGN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

iddqkfyou (< 20)
Submitted April 19, 2010

So can I really be the first to rate this? Yes, they will be out of money in a year, but they are also in phase 3 trials for organ regeneration any chance of patient immune rejection because the organs are made from the cells of the patient. This is… More

zzlangerhans (99.68)
Submitted February 14, 2011

This is a classic case of story vs. reality.The story here is Blade Runner. A future where cyborgs can be constructed from bioengineered human tissue. And any human part that wears out can be replaced with an organ grown in an incubator. Towards that… More

NASDAQ:TNGN VS S&P 500 (SPY)

NASDAQ:TNGN Summary

Fools bearish on NASDAQ:TNGN are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about TNGN.

Recs

0
Member Avatar EDHENWIL (< 20) Submitted: 3/29/2011 4:34:44 AM : Outperform Start Price: $25.10 NASDAQ:TNGN Score: -235.54

TNGN
This is a very unique product.
This is what everybody have dreaming of.
This is the future of our life if your body need parts.
This is already probing and just need a fine tuning.

Recs

0
Member Avatar malicon (29.39) Submitted: 2/17/2011 6:53:46 PM : Outperform Start Price: $30.00 NASDAQ:TNGN Score: -230.30

too low

Recs

3
Member Avatar iddqkfyou (< 20) Submitted: 4/19/2010 6:02:25 PM : Outperform Start Price: $43.30 NASDAQ:TNGN Score: -283.50

So can I really be the first to rate this? Yes, they will be out of money in a year, but they are also in phase 3 trials for organ regeneration any chance of patient immune rejection because the organs are made from the cells of the patient. This is true scalable stem-cell organ regeneration. How much do organs go for on the market? Imagine the the new organs will last patients decades... without nasty immune suppressants...

Market Cap. of 60 big ones.... Sure, wait until you can get it at a better price when they go begging for more cash... but this is one clear case of a myopic market.

All of our organs will fall apart, and soon it will be standard practice to make backups of your stem-cells, preserving your young un-mutated genetic instructions. Again, what will old Japanese and German savers buy in the future if not this... And this company is years ahead.

Leaderboard

Find the members with the highest scoring picks in TNGN.

Score Leader

Zippidy1

Zippidy1 (99.47) Score: +235.44

The Score Leader is the player with the highest score across all their picks in TNGN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Zippidy1 99.47 2/15/2011 Underperform 5Y $59.50 -97.23% +138.22% +235.44 0 Comment
mainakn 65.89 2/15/2011 Underperform 3M $60.80 -97.29% +138.07% +235.36 0 Comment
Transkar < 20 6/13/2011 Underperform 1Y $10.69 -84.57% +148.24% +232.80 0 Comment
walt393 99.93 1/10/2012 Underperform 5Y $9.82 -83.19% +144.88% +228.07 0 Comment
FUZZYMINKINS < 20 5/19/2011 Outperform 5Y $15.20 -89.14% +135.05% -224.20 0 Comment
whomonkyoulus 27.45 7/28/2011 Outperform 5Y $12.60 -86.90% +142.61% -229.52 0 Comment
malicon 29.39 2/18/2011 Outperform 3M $30.00 -94.50% +135.80% -230.30 1 Comment
winning8 < 20 3/9/2011 Outperform NS $29.80 -94.46% +139.46% -233.92 0 Comment
muntwpchf < 20 2/23/2011 Outperform 3Y $28.30 -94.17% +140.49% -234.66 0 Comment
EDHENWIL < 20 3/29/2011 Outperform 3M $25.10 -93.43% +142.11% -235.54 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for TNGN.